BamSEC and AlphaSense Join Forces
Learn More

Estrella Immunopharma Inc.

NASDAQ: ESLA    
Share price (12/23/24): $1.13    
Market cap (12/23/24): $40.9 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 6 pages Amendment No. 2 to Common Stock Purchase Agreement Between Estrella Immunopharma, Inc. and White Lion Capital LLC
12/34/56
EX-10.1
from 8-K 14 pages Employment Agreement
12/34/56
EX-10.1
from 8-K 2 pages Amendment No. 1 to Statement of Work No. 1
12/34/56
EX-10.1
from 8-K 7 pages Statement of Work No. 001 Clinical Trial Services for Eb103 Project
12/34/56
EX-10.20
from 8-K 15 pages Employment Agreement
12/34/56
EX-10.19
from 8-K 15 pages Employment Agreement
12/34/56
EX-10.18
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.17
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.16
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.15
from 8-K 4 pages Unsecured Promissory Note
12/34/56
EX-10.14
from 8-K 19 pages Estrella Biopharma, Inc. 2023 Omnibus Incentive Plan
12/34/56
EX-10.13
from 8-K 10 pages Form of Indemnification Agreement
12/34/56
EX-10.12
from 8-K 3 pages Assignment of Stock Agreement
12/34/56
EX-10.11
from 8-K 3 pages Assignment of Stock Agreement
12/34/56
EX-10.10
from 8-K 3 pages Assignment of Stock Agreement
12/34/56
EX-10.9
from 8-K 5 pages Joinder to Series a Preferred Stock Purchase Agreement
12/34/56
EX-10.8
from 8-K 5 pages Joinder to Series a Preferred Stock Purchase Agreement
12/34/56
EX-10.7
from 8-K 5 pages Joinder to Series a Preferred Stock Purchase Agreement
12/34/56
EX-10.6
from 8-K 5 pages Joinder to Series a Preferred Stock Purchase Agreement
12/34/56
EX-10.5
from 8-K 5 pages Joinder to Series a Preferred Stock Purchase Agreement
12/34/56